Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11867305 | 0.94 | MAPT (0.59) | MAPTCA2CA1CES2ZDHHC7 | |
| SCHEMBL31190396 | 0.92 | MAPT (0.62) | MAPTCA2CES2ZDHHC7CPB2 | |
| SCHEMBL31167494 | 0.92 | MAPT (0.62) | MAPTCA2CES2ZDHHC7CPB2 | |
| SCHEMBL31475548 | 0.92 | MAPT (0.62) | MAPTCA2CES2ZDHHC7CPB2 | |
| SCHEMBL7469525 | 0.92 | MAPT (0.62) | MAPTCA2CES2ZDHHC7CPB2 | |
| SCHEMBL27918416 | 0.87 | MAPT (0.41) | MAPTTDP1ALDH1A1ACHELMNA | |
| SCHEMBL11531078 | 0.86 | ALDH1A1 (0.42) | MAPTTSHRCYP3A4TDP1ALDH1A1 | |
| SCHEMBL27869708 | 0.85 | CPB2 (0.40) | MAPTTDP1ALDH1A1LMNAHSD17B10 | |
| SCHEMBL5749106 | 0.84 | MAPT (0.52) | MAPTCA2CA1TSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL27885999 | 0.83 | CPB2 (0.39) | MAPTTDP1ALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1038861-B1 | 4-FLUORO-3-OXOCARBOXYLIC ESTERS AND PROCESS FOR PRODUCING THE SAME | UBE INDUSTRIES (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6593488-B1 | Reacting 2-fluorocarboxylate with carboxylate | UBE INDUSTRIES, LTD. (JP) | 2003-07-15 | — | — | US | disclosed |
| EP-0817773-B1 | PYRIMIDINE COMPOUNDS | QINETIQ LTD (GB) | 2002-06-12 | — | — | EP | disclosed |
| EP-1038861-A1 | 4-FLUORO-3-OXOCARBOXYLIC ESTERS AND PROCESS FOR PRODUCING THE SAME | UBE INDUSTRIES LIMITED (JP) | 2000-09-27 | — | — | EP | disclosed |
| US-6121448-A | LIQUID CRYSTALLINE COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITTANIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 2000-09-19 | — | — | US | disclosed |
| US-5986096-A | REACTION OF HYDROGEN IODIDE WITH CHLORO-5-BROMOPYRIMIDINE | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S A GOVERNMENT OF THE U.K. OF GT. BRITAIN & N. IRELAND OF DEFENCE EVALUATION & RESEARCH AGENCY (GB) | 1999-11-16 | — | — | US | disclosed |
| WO-1996030344-A9 | PYRIMIDINE COMPOUNDS | — | 1999-02-11 | — | — | WO | disclosed |
| EP-0817773-A2 | PYRIMIDINE COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030344-A2 | PYRIMIDINE COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1996-10-03 | — | — | WO | disclosed |
| US-4410720-A | HYPOTENSIVE AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1983-10-18 | — | — | US | disclosed |
| US-4059576-A | CARDIOVASCULAR, OXYTOCICS | HOFFMANN-LA ROCHE, INC. (US) | 1977-11-22 | — | — | US | disclosed |
| US-4052446-A | OXYTOCICS, CARDIOVASCULAR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1977-10-04 | — | — | US | disclosed |
| US-4036871-A | CARDIOVASCULAR AGENTS, LABOR INDUCERS, ABORTION | HOFFMANN-LA ROCHE INC. (US) | 1977-07-19 | — | — | US | disclosed |
| US-3969379-A | 13,14-Dihydro-16-fluoro prostaglandin A1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969380-A | 16-Fluoro prostaglandin F2 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969381-A | 13,14-Dihydro-16-fluoro prostaglandin B1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969378-A | 16-Fluoro prostaglandin A2 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969377-A | 16-Fluoro prostaglandin E1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3969376-A | 13,14-Dihydro-16-fluoro prostaglandin E1 analogs | THE UPJOHN COMPANY (US) | 1976-07-13 | — | — | US | disclosed |
| US-3962293-A | 13,14-Dihydro-16-fluoro prostaglandin F1 | THE UPJOHN COMPANY (US) | 1976-06-08 | — | — | US | disclosed |